Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression-Reference-Cited by-同舟云学术

Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression

Published:2013-06 Issue:6 Volume:78 Page:548-554
ISSN:0039-128X
Container-title:Steroids
language:en
Short-container-title:Steroids

Author:

Shafi Ayesha A.,Cox Marc B.,Weigel Nancy L.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Pharmacology,Endocrinology,Molecular Biology,Biochemistry

Reference29 articles.

1. Identification of a clinically relevant androgen-dependent gene signature in prostate cancer;Heemers;Cancer Res,2011

2. Androgen receptor signaling and mutations in prostate cancer;Koochekpour;Asian J Androl,2010

3. Androgen receptor action in hormone-dependent and recurrent prostate cancer;Agoulnik;J Cell Biochem,2006

4. Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy;Ryan;J Clin Oncol,2010

5. Effect of MDV3100 an androgen receptor signaling inhibitor (ARSI) on overall survival in patients with prostate cancer postdocetaxel results from the phase III AFFIRM study;Scher;J Clin Oncol,2012

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative splicing in prostate cancer progression and therapeutic resistance;Oncogene;2024-04-24

2. IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer;iScience;2024-02

3. HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers;Nucleic Acids Research;2023-08-28

4. HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers;2023-05-08

5. Impact of FKBP52 on cell proliferation and hormone‐dependent cancers;Cancer Science;2023-04-27